Skip to Content
Symphonies
Top Patent Approvals 2010-2017
Today’s Change
—

A symphony is an automated trading strategy — Learn more about symphonies here

About

Own the companies that ranked highest for patent approvals in 2010–2017—an innovation proxy. Equal-weight the top 25 and rebalance quarterly. Skews toward semiconductors, electronics, software, and industrials.
NutHow it works
It buys companies that were frequent patent winners in 2010–2017. Each year, firms are ranked by patent approvals; those yearly ranks are averaged to find steady leaders. The top 25 are owned in equal slices and reset every 3 months. Expect a tilt to chips/electronics, software, and industrials (e.g., IBM, MSFT, INTC, TSM, QCOM, AVGO, AMAT, TXN, SONY, GE, HON, BA, MDT, PG, NKE). Patents here act as a simple proxy for ongoing R&D.
CheckmarkValue prop
Out-of-sample annualized return: 24.72% vs SPY 24.08%; Calmar 1.05. A patent-driven, equal-weighted 25-name portfolio tilts to innovation leaders, reduces mega-cap bias, and offers solid risk-adjusted upside with controlled drawdowns.

Loading backtest data...

Invest in this strategy
OOS Start Date
Mar 24, 2023
Trading Setting
Quarterly
Type
Stocks
Category
Innovation, patents, equal-weight, long-only equities, tech-heavy, semiconductors, software, industrials, quarterly rebalance
Tickers in this symphonyThis symphony trades 0 assets in total
Ticker
Type

FAQ

A Composer symphony is an automated trading strategy that executes trades based on parameters of your choice. Some symphonies are similar to holding one ETF in normal conditions and rotating to a different ETF when market conditions shift, for example a 5% drop in the S&P 500, while others use complex rules with dozens of triggers. However, complex doesn’t always mean better. A simple, well-structured symphony can be just as effective as an intricate one. Learn more about how symphonies work here.

"Top Patent Approvals 2010-2017" is currently performing the same as yesterday today. Performance updates in real time during market hours.

"Top Patent Approvals 2010-2017" is currently allocated toLPL, MU, AMAT, AVGO, INTC, QCOM, TXN, GE, HON, SAP, LPLA, HMC, BA, AAPL, ORCL, SONY, XRX, TSM, MDT, PG, MSFT, NKE, IBMandBKR. Holdings automatically adjust as market conditions change based on the strategy's rules.

Year-to-date, "Top Patent Approvals 2010-2017" has returned 24.72%. You can adjust the performance chart above to view returns across different time horizons.

The maximum drawdown for "Top Patent Approvals 2010-2017" is 23.56%. The maximum drawdown measures the largest peak-to-trough decline. It's an important metric to evaluate risk and the strategy's behavior during market stress.

To invest in "Top Patent Approvals 2010-2017", simply click the Invest button on this page. You'll need to open an account with Composer if you don't have one yet, then you can start investing. Composer will automatically execute the trades for you based on the strategy's rules. Composer also supports trading individual stocks, ETFs, crypto, and options.